Your browser doesn't support javascript.
loading
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trial.
Zhang, Liulu; Wu, Zhi-Yong; Li, Jie; Lin, Ying; Liu, Zhenzhen; Cao, Yin; Zhang, Gangling; Gao, Hong-Fei; Yang, Mei; Yang, Ci-Qiu; Zhu, Teng; Cheng, Min-Yi; Ji, Fei; Li, Jieqing; Wang, Kun.
Afiliação
  • Zhang L; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Wu ZY; Diagnosis & Treatment Center of Breast Diseases, Shantou Central Hospital, Shantou, China.
  • Li J; Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Lin Y; Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Liu Z; Department of Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Cao Y; Breast Central, Dongguan People's Hospital, Dongguan, China.
  • Zhang G; Department of Breast Surgery, Baotou Cancer Hospital, Baotou, China.
  • Gao HF; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yang M; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yang CQ; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhu T; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Cheng MY; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Ji F; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Li J; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Wang K; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Int J Cancer ; 150(4): 654-662, 2022 02 15.
Article em En | MEDLINE | ID: mdl-34591977
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China